Changing seroprevalence of schistosomiasis japonica in China from 1982 to 2020: A systematic review and spatial analysis. [PDF]
PLoS Negl Trop DisBackground Schistosomiasis is a global public health issue. In China, while the seroprevalence of Schistosomiasis japonica has currently reduced to a relatively low level, risk of infection still exists in certain areas. However, there has been a lack of
Zhou Y +10 more
europepmc +2 more sources
A CASE OF SCHISTOSOMIASIS JAPONICA. [PDF]
The Lancet, 1914 n ...
Harry N White
openalex +4 more sources
Elimination of Schistosomiasis Japonica in China: From the One Health Perspective. [PDF]
China CDC Wkly, 2022 Schistosomiasis japonica is caused by infection of Schistosoma japonicum (S. japonicum), which infected 12 million residents in the 1950s in China and was a heavy burden to public health and socioeconomic development (1). After more than seven decades of
Hong Z +6 more
europepmc +2 more sources
Experimental cerebral schistosomiasis japonica in primates [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 1970 Aspects of the pathogenesis of cerebral schistosomiasis have been elucidated. Arterial embolization alone, by either worms or eggs, does not appear to be likely as a major cause of the disease. When large numbers of eggs enter the brain, sensitization may play a role in the occurrence of neurological signs.
John A. Jane +2 more
openalex +4 more sources
Diagnostic performance of a urine-based ELISA assay for the screening of human schistosomiasis japonica: A comparative study. [PDF]
Front Microbiol, 2022 The current study developed and evaluated the performance of a urine-based enzyme-linked immunosorbent assay (ELISA) for the screening of Schistosoma japonicum infection in a human cohort (n = 412) recruited from endemic areas, Northern Samar, the ...
Mu Y +5 more
europepmc +2 more sources
Dysregulated Glucuronidation of Bilirubin Exacerbates Liver Inflammation and Fibrosis in Schistosomiasis Japonica through the NF-κB Signaling Pathway. [PDF]
PathogensHepatic fibrosis is an important pathological manifestation of chronic schistosome infection. Patients with advanced schistosomiasis show varying degrees of abnormalities in liver fibrosis indicators and bilirubin metabolism.
Xue Q +10 more
europepmc +2 more sources
Ecological model to predict potential habitats of Oncomelania hupensis, the intermediate host of Schistosoma japonicum in the mountainous regions, China [PDF]
, 2015 Schistosomiasis japonica is a parasitic disease that remains endemic in seven provinces in the People's Republic of China (P.R. China). One of the most important measures in the process of schistosomiasis elimination in P.R.
Liu, Lu +3 more
core +19 more sources
IMMUNOLOGICAL STUDIES ON SCHISTOSOMIASIS JAPONICA
The KITAKANTO Medical Journal, 1960 Immunization of animals with adultworm-and egg-antigen and passive immunization with antiserum were performed. With these animals, precipitin tests, change of serum protein and protection against reinfection were studied.I. protection against infection of S.
Tae Nakajima
openalex +4 more sources
Performance of the point-of-care circulating cathodic antigen test in the diagnosis of schistosomiasis japonica in a human cohort from Northern Samar, the Philippines. [PDF]
Infect Dis Poverty, 2021 Background Zoonotic schistosomiasis, caused by Schistosoma japonicum , remains a major public health problem in the Philippines. This study aimed to evaluate the commercially available rapid diagnostic point-of-care circulating cathodic antigen (POC-CCA)
Cai P +5 more
europepmc +2 more sources
IL-33/ST2 Axis Deficiency Exacerbates Hepatic Pathology by Regulating Treg and Th17 Cells in Murine Schistosomiasis Japonica. [PDF]
J Inflamm Res, 2021 Purpose Schistosoma japonicum-infected IL-33 and ST2 gene deficiency (IL-33−/− and ST2−/−, respectively) mice were used to explore the role of the IL-33/ST2 axis in liver pathology targeting regulatory T cells (Treg)/T helper 17 cells (Th17).
Bai Y +7 more
europepmc +2 more sources